Tu XX - Search Results

1

Antibiotics and immunotherapy in gastrointestinal tumors: Friend or foe?

Yan C, Tu XX, Wu W, Tong Z, Liu LL, Zheng Y, Jiang WQ, Zhao P, Fang WJ, Zhang HY. Yan C, et al. Among authors: tu xx. World J Clin Cases. 2019 Jun 6;7(11):1253-1261. doi: 10.12998/wjcc.v7.i11.1253. World J Clin Cases. 2019. PMID: 31236389 Free PMC article. Review.

2

A randomised phase II study of second-line XELIRI regimen versus irinotecan monotherapy in advanced biliary tract cancer patients progressed on gemcitabine and cisplatin.

Zheng Y, Tu X, Zhao P, Jiang W, Liu L, Tong Z, Zhang H, Yan C, Fang W, Wang W. Zheng Y, et al. Br J Cancer. 2018 Aug;119(3):291-295. doi: 10.1038/s41416-018-0138-2. Epub 2018 Jun 29. Br J Cancer. 2018. PMID: 29955136 Free PMC article. Clinical Trial.

3

Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma.

Zheng Y, Wang T, Tu X, Huang Y, Zhang H, Tan D, Jiang W, Cai S, Zhao P, Song R, Li P, Qin N, Fang W. Zheng Y, et al. J Immunother Cancer. 2019 Jul 23;7(1):193. doi: 10.1186/s40425-019-0650-9. J Immunother Cancer. 2019. PMID: 31337439 Free PMC article.

4

Nutrition and metabolism status alteration in advanced hepatocellular carcinoma patients treated with anti-PD-1 immunotherapy.

Jiang Y, Tu X, Zhang X, Liao H, Han S, Jiang W, Zheng Y, Zhao P, Tong Z, Fu Q, Qi Q, Shen J, Zhong L, Pan Y, Fang W. Jiang Y, et al. Support Care Cancer. 2020 Nov;28(11):5569-5579. doi: 10.1007/s00520-020-05478-x. Epub 2020 May 2. Support Care Cancer. 2020. PMID: 32361828

5

Ultra-stable Biomembrane Force Probe for Accurately Determining Slow Dissociation Kinetics of PD-1 Blockade Antibodies on Single Living Cells.

An C, Hu W, Gao J, Ju BF, Obeidy P, Zhao YC, Tu X, Fang W, Ju LA, Chen W. An C, et al. Nano Lett. 2020 Jul 8;20(7):5133-5140. doi: 10.1021/acs.nanolett.0c01360. Epub 2020 Jun 22. Nano Lett. 2020. PMID: 32530632

6

Interleukin-33 as an early predictor of cetuximab treatment efficacy in patients with colorectal cancer.

Zhang X, Bi K, Tu X, Zhang Q, Cao Q, Liang Y, Zeng P, Wang L, Liu T, Fang W, Diao H. Zhang X, et al. Cancer Med. 2021 Dec;10(23):8338-8351. doi: 10.1002/cam4.4331. Epub 2021 Oct 19. Cancer Med. 2021. PMID: 34664425 Free PMC article.

7

Single-cell immune signature for detecting early-stage HCC and early assessing anti-PD-1 immunotherapy efficacy.

Shi J, Liu J, Tu X, Li B, Tong Z, Wang T, Zheng Y, Shi H, Zeng X, Chen W, Yin W, Fang W. Shi J, et al. J Immunother Cancer. 2022 Jan;10(1):e003133. doi: 10.1136/jitc-2021-003133. J Immunother Cancer. 2022. PMID: 35101942 Free PMC article. Clinical Trial.

8

Advances in CAR-T cell therapy for malignant solid tumors.

Liu J, Tu X, Liu L, Fang W. Liu J, et al. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022 Apr 25;51(2):175-184. doi: 10.3724/zdxbyxb-2022-0044. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022. PMID: 36161290 Free PMC article. Review. English.

9

S100A9⁺CD14⁺ monocytes contribute to anti-PD-1 immunotherapy resistance in advanced hepatocellular carcinoma by attenuating T cell-mediated antitumor function.

Tu X, Chen L, Zheng Y, Mu C, Zhang Z, Wang F, Ren Y, Duan Y, Zhang H, Tong Z, Liu L, Sun X, Zhao P, Wang L, Feng X, Fang W, Liu X. Tu X, et al. J Exp Clin Cancer Res. 2024 Mar 8;43(1):72. doi: 10.1186/s13046-024-02985-1. J Exp Clin Cancer Res. 2024. PMID: 38454445 Free PMC article.

10

Tanshinone IIA modulates cancer cell morphology and movement via Rho GTPases-mediated actin cytoskeleton remodeling.

Liang EY, Huang MH, Chen YT, Zhang PW, Shen Y, Tu XX, Chen WY, Wang Y, Yan J, Wang HY, Ke PF, Huang XZ. Liang EY, et al. Among authors: tu xx. Toxicol Appl Pharmacol. 2024 Feb;483:116839. doi: 10.1016/j.taap.2024.116839. Epub 2024 Jan 28. Toxicol Appl Pharmacol. 2024. PMID: 38290667

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page